Circulation-Genomic and Precision Medicine

Scope & Guideline

Advancing Precision in Cardiovascular Care

Introduction

Welcome to the Circulation-Genomic and Precision Medicine information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Circulation-Genomic and Precision Medicine, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN2574-8300
PublisherLIPPINCOTT WILLIAMS & WILKINS
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2018 to 2024
AbbreviationCIRC-GENOM PRECIS ME / Circ.-Genom. Precis. Med.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressTWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103

Aims and Scopes

The journal 'Circulation-Genomic and Precision Medicine' focuses on advancing the understanding of cardiovascular diseases through genomic and precision medicine approaches. It aims to bridge the gap between basic research and clinical practice by providing insights into genetic determinants, molecular mechanisms, and innovative therapeutic strategies.
  1. Genomic Insights into Cardiovascular Diseases:
    The journal emphasizes the role of genetic factors in cardiovascular diseases, exploring how genetic variations influence disease susceptibility, progression, and treatment outcomes.
  2. Precision Medicine Approaches:
    It promotes the application of precision medicine principles, aiming to tailor prevention and treatment strategies based on individual genetic profiles and other biomarkers.
  3. Multidisciplinary Methodologies:
    The journal encompasses a wide range of methodologies, including genomics, transcriptomics, proteomics, and metabolomics, to provide a comprehensive understanding of cardiovascular health.
  4. Population Diversity and Health Disparities:
    There is a consistent focus on studying diverse populations to understand how genetic and environmental factors contribute to cardiovascular health disparities.
  5. Translational Research:
    The journal encourages research that translates findings from the laboratory to clinical settings, emphasizing the practical implications of genomic research in patient care.
The journal has seen a rise in certain themes that reflect the current advancements and interests in cardiovascular research, particularly those that leverage genomic technologies and precision medicine.
  1. Polygenic Risk Scores and Predictive Analytics:
    There is an increasing focus on developing and validating polygenic risk scores to enhance the prediction of cardiovascular diseases, indicating a trend towards integrating genetic data into clinical risk assessment.
  2. Multi-Omic Approaches:
    Emerging studies are increasingly utilizing multi-omic approaches, integrating genomics, proteomics, and metabolomics to provide a holistic view of cardiovascular health and disease mechanisms.
  3. Health Disparities and Genomic Diversity:
    An upward trend is observed in research addressing health disparities among diverse populations, emphasizing the need for inclusive genomic research that considers ethnic and racial differences.
  4. Gene Therapy and Innovative Treatments:
    Research on gene therapy and innovative treatment strategies for inherited cardiovascular conditions is gaining momentum, reflecting advancements in genetic engineering and therapeutic interventions.
  5. Application of Machine Learning in Genomics:
    The integration of machine learning techniques to analyze complex genomic data and improve diagnostic accuracy is becoming a significant theme, showcasing the intersection of artificial intelligence and precision medicine.

Declining or Waning

While 'Circulation-Genomic and Precision Medicine' continues to thrive in various research domains, certain themes are experiencing a decline in publication frequency, indicating a potential shift in focus or evolving research interests.
  1. Traditional Epidemiological Studies:
    There has been a noticeable reduction in traditional epidemiological studies focused solely on risk factor associations without integrating genomic data, reflecting a shift towards more comprehensive approaches that combine genetics with clinical and lifestyle factors.
  2. Single-Gene Disorders:
    Research centered on single-gene disorders related to cardiovascular diseases is becoming less prominent as the field moves towards understanding polygenic contributions and multifactorial interactions.
  3. Basic Mechanistic Studies:
    While basic mechanistic studies are essential, there appears to be a waning interest in studies that do not directly translate into clinical applications or precision medicine approaches.

Similar Journals

Annual Review of Genomics and Human Genetics

Illuminating the Pathways of Molecular Biology
Publisher: ANNUAL REVIEWSISSN: 1527-8204Frequency: 1 issue/year

Annual Review of Genomics and Human Genetics, published by ANNUAL REVIEWS, represents a pivotal platform in the field of Genetics and Molecular Biology. With an impressive impact factor reflecting its high citation rate and scholarly influence, this journal is renowned for its authoritative reviews that synthesize current research across genomics and human genetics. Highlighting its Q1 category rankings in both Genetics and Clinical Genetics, as well as its ranking within the top tiers of Biochemistry and Genetics, the journal stands out as a leading resource for researchers, professionals, and students eager to stay abreast of groundbreaking developments in these rapidly evolving fields. While not currently an open access journal, its rigorous peer-review process ensures the highest standards of scientific integrity. Researchers can access comprehensive reviews that delve into both fundamental genetics concepts and cutting-edge discoveries, making it an essential resource for advancing understanding in human genetics and its applications.

Global Medical Genetics

Transforming Healthcare Through Genetic Insights
Publisher: GEORG THIEME VERLAG KGISSN: 2699-9404Frequency: 4 issues/year

Global Medical Genetics is a premier open-access journal dedicated to advancing the field of medical genetics. Published by GEORG THIEME VERLAG KG, this journal has been providing a dynamic platform for disseminating cutting-edge research and clinical findings since its inception in 2020. With the ISSN 2699-9404, it serves as an essential resource for researchers, healthcare professionals, and students who seek to explore the complex interplay between genetics and medicine. The journal aims to foster collaboration and innovation in the genetics community, addressing a diverse range of topics from genetic disorders to the application of genomics in personalized medicine. By providing open access to its content, Global Medical Genetics enhances knowledge sharing and accelerates advancements in healthcare, making it a vital asset for anyone invested in the future of genetics.

Precision Clinical Medicine

Shaping tomorrow's healthcare, today.
Publisher: OXFORD UNIV PRESSISSN: 2096-5303Frequency: 4 issues/year

Precision Clinical Medicine, published by Oxford University Press, is an esteemed open-access journal that has been at the forefront of clinical research since its inception in 2018. With an ISSN of 2096-5303, this journal specializes in the rapidly evolving field of precision medicine, which aims to tailor healthcare to individual patient characteristics, needs, and preferences. As a testament to its influence, Precision Clinical Medicine holds a remarkable rank of #34 out of 636 in the General Medicine category on Scopus, placing it within the 94th percentile of its field and earning a prestigious Q1 rating in 2023. Based in the United Kingdom, the journal not only provides open access content, ensuring that groundbreaking research is widely disseminated, but also serves as a crucial platform for innovations and discussions that shape modern medical practices. Researchers, professionals, and students alike will find valuable insights and influential studies that drive the future of personalized healthcare within its pages.

Nature Cardiovascular Research

Transforming research into impactful cardiovascular solutions.
Publisher: SPRINGERNATUREISSN: Frequency: 12 issues/year

Nature Cardiovascular Research, published by SpringerNature in Germany, stands as a premier journal dedicated to advancing the field of cardiovascular sciences. With an impressive 2023 categorization in the Q1 quartile across multiple disciplines—including Biochemistry, Genetics and Molecular Biology, Cardiology, and Medicine—this journal uniquely positions itself as a leading resource for pioneering research and innovative findings. Although currently not open access, it provides a rich repository of peer-reviewed articles that contribute directly to the evolving landscape of cardiovascular medicine. The journal aims to bridge the knowledge gap between basic science and clinical application, catering to researchers, healthcare professionals, and students alike who are immersed in the complexities of cardiovascular health. With robust Scopus rankings in key categories, Nature Cardiovascular Research is poised to shape future directions in the field, helping to foster a deeper understanding of cardiovascular diseases and their underlying mechanisms. Explore the latest research and be part of the conversation in one of the most impactful scientific domains.

Current Genetic Medicine Reports

Transforming Healthcare with Genetic Discoveries
Publisher: SPRINGERNATUREISSN: Frequency: 4 issues/year

Current Genetic Medicine Reports, published by SPRINGERNATURE, is a prominent journal dedicated to advancing the field of genetic medicine. With an emphasis on the latest research and advancements, this journal serves as a critical platform for disseminating high-quality original articles, reviews, and reports that focus on the application of genetic information in various medical disciplines. As an open-access journal, it ensures that valuable findings are freely accessible to a global audience, thereby fostering collaboration and innovation among researchers, healthcare professionals, and students alike. Although the journal does not yet have an established impact factor, its commitment to rigorous peer review and its contributions to the understanding and integration of genetic medicine into clinical practice enhance its scholarly significance. The editorial board is comprised of leading experts, encouraging submissions that tackle contemporary issues in genetic research and its clinical applications. Located in London, England, this journal is poised to be a vital resource for those seeking to stay abreast of the rapid changes in the dynamic field of genetic medicine.

CARDIOVASCULAR RESEARCH

Pioneering discoveries in cardiology and physiology.
Publisher: OXFORD UNIV PRESSISSN: 0008-6363Frequency: 18 issues/year

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

Clinica e Investigacion en Arteriosclerosis

Exploring innovative solutions in arterial disease management.
Publisher: ELSEVIERISSN: 0214-9168Frequency: 6 issues/year

Clinica e Investigacion en Arteriosclerosis is a premier academic journal dedicated to the field of cardiology and cardiovascular medicine, published by ELSEVIER. With its ISSN 0214-9168 and E-ISSN 1578-1879, the journal aims to disseminate high-quality research and innovations in the understanding and treatment of arterial diseases, contributing significantly to both clinical practices and pharmacological advancements. Established in 2007 and continuing into 2024, the journal has garnered recognition with a notable Q3 categorization in both Cardiology and Cardiovascular Medicine and Pharmacology (medical) for 2023, reflecting its impact in the academic community. Researchers and healthcare professionals utilizing this journal will find a diverse range of articles exploring novel therapeutic strategies and epidemiological data, making it an essential resource for advancing knowledge and practice in cardiovascular health. While it does not operate as an open-access journal, the findings published in Clinica e Investigacion en Arteriosclerosis are pivotal for understanding current trends and future directions in cardiovascular research.

Cardiogenetics

Innovating research at the intersection of genetics and heart disease.
Publisher: MDPIISSN: 2035-8253Frequency: 4 issues/year

Cardiogenetics, published by MDPI, is a leading open-access journal dedicated to advancing the field of genetics as it pertains to cardiovascular health and diseases. Since its launch in 2011, this journal has been at the forefront of disseminating high-quality research that explores the genetic underpinnings of cardiovascular conditions, offering a platform for innovative studies, reviews, and case reports. With an ISSN of 2035-8253 and an E-ISSN of 2035-8148, Cardiogenetics aims to bridge the gap between genetic research and clinical application, helping researchers, healthcare professionals, and students stay abreast of the latest advancements and findings. The journal’s commitment to open access ensures that its valuable content is available to a global audience, fostering greater collaboration and knowledge sharing in the cardiovascular genetics community. By contributing to this dynamic field, Cardiogenetics plays a crucial role in improving patient outcomes and paving the way for personalized medicine in cardiology.

Precision and Future Medicine

Advancing the frontiers of personalized healthcare.
Publisher: SUNGKYUNKWAN UNIV SCH MEDICINEISSN: 2508-7940Frequency: 4 issues/year

Precision and Future Medicine is an esteemed academic journal published by Sungkyunkwan University School of Medicine, dedicated to advancing the fields of precision medicine and healthcare innovation. Established as an Open Access journal in 2017, it aims to disseminate cutting-edge research and insights that bridge the gap between basic and clinical sciences. With a focus on personalized medicine, genomics, and advanced therapeutic strategies, the journal serves as a vital resource for researchers, clinicians, and policy makers. Set in the dynamic environment of South Korea, Precision and Future Medicine provides a platform for the exchange of ideas that are shaping the future of medical science, thus contributing significantly to the global dialogue on health and wellness. As it continues to grow, the journal is committed to ensuring that high-quality research remains accessible to all, fostering a spirit of collaboration and innovation within the scientific community.

Expert Review of Precision Medicine and Drug Development

Exploring the future of drug discovery and molecular medicine.
Publisher: TAYLOR & FRANCIS LTDISSN: 2380-8993Frequency: 6 issues/year

Expert Review of Precision Medicine and Drug Development, published by Taylor & Francis Ltd, is a valuable academic resource that thrives at the intersection of pharmacology, genetics, and molecular medicine. Since its inception in 2016, this journal has rapidly become a pivotal platform for researchers and practitioners aiming to advance the field of drug development through innovative precision medicine strategies. With a broad focus encompassing the latest advancements in drug discovery and genetic research, it operates within a competitive landscape, evidenced by its recent category quartile rankings where it holds Q4 in Drug Discovery, Genetics, and Molecular Medicine, alongside a Q3 ranking in Pharmacology for the year 2023. The journal offers a unique opportunity for scholars to share insights and foster collaborations that can lead to breakthroughs in therapeutic approaches. Although not an open-access journal, it maintains a commitment to disseminating outstanding research to a wide audience. By fostering a rigorous peer-review process, the journal aims to enhance the quality and impact of publications within these critical areas of medicine, making it an essential read for anyone involved in healthcare and pharmaceutical advancements.